» Articles » PMID: 23798437

Rasip1 Mediates Rap1 Regulation of Rho in Endothelial Barrier Function Through ArhGAP29

Overview
Specialty Science
Date 2013 Jun 27
PMID 23798437
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Rap1 is a small GTPase regulating cell-cell adhesion, cell-matrix adhesion, and actin rearrangements, all processes dynamically coordinated during cell spreading and endothelial barrier function. Here, we identify the adaptor protein ras-interacting protein 1 (Rasip1) as a Rap1-effector involved in cell spreading and endothelial barrier function. Using Förster resonance energy transfer, we show that Rasip1 interacts with active Rap1 in a cellular context. Rasip1 mediates Rap1-induced cell spreading through its interaction partner Rho GTPase-activating protein 29 (ArhGAP29), a GTPase activating protein for Rho proteins. Accordingly, the Rap1-Rasip1 complex induces cell spreading by inhibiting Rho signaling. The Rasip1-ArhGAP29 pathway also functions in Rap1-mediated regulation of endothelial junctions, which controls endothelial barrier function. In this process, Rasip1 cooperates with its close relative ras-association and dilute domain-containing protein (Radil) to inhibit Rho-mediated stress fiber formation and induces junctional tightening. These results reveal an effector pathway for Rap1 in the modulation of Rho signaling and actin dynamics, through which Rap1 modulates endothelial barrier function.

Citing Articles

Whole blood gene expression analysis of spontaneous hypertriglyceridemia in dogs suggests an underlying pro-thrombotic process.

Baker L, Minor K, Tate N, Furrow E PLoS One. 2024; 19(11):e0313343.

PMID: 39531449 PMC: 11556679. DOI: 10.1371/journal.pone.0313343.


Initiation of lumen formation from junctions via differential actomyosin contractility regulated by dynamic recruitment of Rasip1.

Yin J, Schellinx N, Maggi L, Gundel K, Wiesner C, Kotini M Nat Commun. 2024; 15(1):9714.

PMID: 39521779 PMC: 11550478. DOI: 10.1038/s41467-024-54143-y.


A novel ARHGAP family gene signature for survival prediction in glioma patients.

Huang J, Wang G, Zhang J, Liu Y, Shen Y, Chen G J Cell Mol Med. 2024; 28(14):e18555.

PMID: 39075640 PMC: 11286547. DOI: 10.1111/jcmm.18555.


ARHGAP29 Is Involved in Increased Invasiveness of Tamoxifen-resistant Breast Cancer Cells and its Expression Levels Correlate With Clinical Tumor Parameters of Breast Cancer Patients.

Kansy M, Wert K, Kolb K, Gallwas J, Grundker C Cancer Genomics Proteomics. 2024; 21(4):368-379.

PMID: 38944420 PMC: 11215425. DOI: 10.21873/cgp.20454.


Molecular Mechanisms Regulating Vascular Endothelial Permeability.

Wakasugi R, Suzuki K, Kaneko-Kawano T Int J Mol Sci. 2024; 25(12).

PMID: 38928121 PMC: 11203514. DOI: 10.3390/ijms25126415.


References
1.
Pannekoek W, van Dijk J, Chan O, Huveneers S, Linnemann J, Spanjaard E . Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell Signal. 2011; 23(12):2056-64. DOI: 10.1016/j.cellsig.2011.07.022. View

2.
Stockton R, Shenkar R, Awad I, Ginsberg M . Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med. 2010; 207(4):881-96. PMC: 2856024. DOI: 10.1084/jem.20091258. View

3.
Ahmed S, Daulat A, Meunier A, Angers S . G protein betagamma subunits regulate cell adhesion through Rap1a and its effector Radil. J Biol Chem. 2010; 285(9):6538-51. PMC: 2825450. DOI: 10.1074/jbc.M109.069948. View

4.
Xu K, Chong D, Rankin S, Zorn A, Cleaver O . Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol. 2009; 329(2):269-79. PMC: 2683470. DOI: 10.1016/j.ydbio.2009.02.033. View

5.
Arthur W, Burridge K . RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell. 2001; 12(9):2711-20. PMC: 59706. DOI: 10.1091/mbc.12.9.2711. View